Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Gastroenterology. 2017 May;152(6):1629-1630. doi: 10.1053/j.gastro.2016.09.068. Epub 2017 Apr 1.

Authors

Cong Dai¹, Min Jiang¹, Ming-Jun Sun¹

Affiliation

¹ Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.

PMID: 28376323
DOI: 10.1053/j.gastro.2016.09.068

No abstract available

Publication types

Letter
Comment

MeSH terms

Diarrhea
Humans
Irritable Bowel Syndrome*
Rifamycins*
Rifaximin

Substances

Rifamycins
Rifaximin